Electroacupuncture versus celecoxib for neuropathic pain in rat SNL model

Neuroscience

Volumn 170, Issue 2, 2010, Pages 655-661

  Lau, W K ^a   Lau, Y M ^a   Zhang, H Q ^a   Wong, S C ^a   Bian, Z X ^a  

^a HONG KONG BAPTIST UNIVERSITY   (Hong Kong)

Author keywords

Acupuncture; Celecoxib; COX 2; Neuropathic pain; Spinal dorsal horn

Indexed keywords

CELECOXIB; CEREBREX; CYCLOOXYGENASE 2; UNCLASSIFIED DRUG;

ADULT ANIMAL; ANALGESIA; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG MECHANISM; ELECTROACUPUNCTURE; ELECTROSTIMULATION THERAPY; ENZYME INHIBITION; HEAT SENSITIVITY; IMAGE ANALYSIS; IMMUNOFLUORESCENCE; LATENT PERIOD; MALE; MECHANICAL STIMULATION; NERVE LIGATION; NEUROPATHIC PAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SPINAL CORD; SPINAL CORD DORSAL HORN; SPINAL NERVE;

ACUPUNCTURE POINTS; ANALGESICS; ANIMALS; CYCLOOXYGENASE 2; DISEASE MODELS, ANIMAL; ELECTROACUPUNCTURE; LIGATION; MALE; NEURALGIA; PAIN THRESHOLD; PYRAZOLES; RATS; RATS, SPRAGUE-DAWLEY; SPINAL CORD; SPINAL NERVES; SULFONAMIDES;

EID: 77956182396     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2010.07.031     Document Type: Article

References (32)

1. Bingham S., Beswick P.J., Bountra C., Brown T., Campbell I.B., Chessell I.P., Clayton N., Collins S.D., Davey P.T., Goodland H., Gray N., Haslam C., Hatcher J.P., Hunter A.J., Lucas F., Murkitt G., Naylor A., Pickup E., Sargent B., Summerfield S.G., Stevens A., Stratton S.C., Wiseman J. The cyclooxygenase-2 inhibitor GW406381X [2-(4-Ethoxyphenyl)-3-[4-(methylsulfonyl)phenyl]-pyrazolo [1,5-b]pyridazine] is effective in animal models of neuropathic pain and central sensitization. J Pharmacol Exp Ther 2005, 312:1161-1169.
2. Bombardier C., Laine L., Reicin A., Shapiro D., Burgos-Vargas R., Davis B., Day R., Ferraz M.B., Hawkey C.J., Hochberg M.C., Kvien T.K., Schnitzer T.J. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. N Engl J Med 2000, 343:1520-1528.
3. Broom D.C., Samad T.A., Kohno T., Tegeder I., Geisslinger G., Woolf C.J. Cyclooxygenase 2 expression in the spared nerve injury model of neuropathic pain. Neuroscience 2004, 124:891-900.
4. Ceccherelli F., Gagliardi G., Visentin R., Sandona F., Casale R., Giron G. The effects of parachlorophenylalanine and naloxone on acupuncture and electroacupuncture modulation of capsaicin-induced neurogenic edema in the rat hind paw. A controlled blind study. Clin Exp Rheumatol 1999, 17:655-662.
5. Cherkin D.C., Sherman K.J., Deyo R.A., Shekelle P.G. A review of the evidence for the effectiveness, safety, and cost of acupuncture, massage therapy, and spinal manipulation for back pain. Ann Intern Med 2003, 138:898-906.
6. Dai Y., Kondo E., Fukuoka T., Tokunaga A., Miki K., Noguchi K. The effect of electroacupuncture on pain behaviors and noxious stimulus-evoked Fos expression in a rat model of neuropathic pain. J Pain 2001, 2:151-159.
7. Durrenberger P.F., Facer P., Casula M.A., Yiangou Y., Gray R.A., Chessell I.P., Day N.C., Collins S.D., Bingham S., Wilson A.W., Elliot D., Birch R., Anand P. Prostanoid receptor EP1 and Cox-2 in injured human nerves and a rat model of nerve injury: a time-course study. BMC Neurol 2006, 6:1.
8. Han J.S. Mechanisms of acupuncture analgesia 1999, Shanghai Science, Technology and Education Publishing House, Shanghai.
9. Hargreaves K., Dubner R., Brown F., Flores C., Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 1988, 32:77-88.
10. Huang C., Li H.T., Shi Y.S., Han J.S., Wan Y. Ketamine potentiates the effect of electroacupuncture on mechanical allodynia in a rat model of neuropathic pain. Neurosci Lett 2004, 368:327-331.
11. Hwang B.G., Min B.I., Kim J.H., Na H.S., Park D.S. Effects of electroacupuncture on the mechanical allodynia in the rat model of neuropathic pain. Neurosci Lett 2002, 320:49-52.
12. Kaptchuk T.J. Acupuncture: theory, efficacy, and practice. Ann Intern Med 2002, 136:374-383.
13. Kim J.H., Min B.I., Na H.S., Park D.S. Relieving effects of electroacupuncture on mechanical allodynia in neuropathic pain model of inferior caudal trunk injury in rat: mediation by spinal opioid receptors. Brain Res 2004, 998:230-236.
14. Kim S.H., Chung J.M. An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain 1992, 50:355-363.
15. Lashbrook J.M., Ossipov M.H., Hunter J.C., Raffa R.B., Tallarida R.J., Porreca F. Synergistic antiallodynic effects of spinal morphine with ketorolac and selective. Pain 1999, 82:65-72.
16. Lau W.K., Chan W.K., Zhang J.L., Yung K.K.L., Zhang H.Q. Electroacupuncture inhibits cyclooxygenase-2 up-regulation in rat spinal cord after spinal nerve ligation. Neuroscience 2008, 155:463-468.
17. Lau W.K., Lui P.W., Wong C.K., Chan Y.S., Yung K.K. Differential expression of N-methyl-d-aspartate receptor subunit messenger ribonucleic acids and immunoreactivity in the rat neostriatum during postnatal development. Neurochem Int 2003, 43:47-65.
18. Ma W., Eisenach J.C. Morphological and pharmacological evidence for the role of peripheral prostaglandins in the pathogenesis of neuropathic pain. Eur J Neurosci 2002, 15:1037-1047.
19. Ma W., Eisenach J.C. Cyclooxygenase 2 in infiltrating inflammatory cells in injured nerve is universally up-regulated following various types of peripheral nerve injury. Neuroscience 2003, 121:691-704.
20. O'Rielly D.D., Loomis C.W. Increased expression of cyclooxygenase and nitric oxide isoforms, and exaggerated sensitivity to prostaglandin E2, in the rat lumbar spinal cord 3 days after L5-L6 spinal nerve ligation. Anesthesiology 2006, 104:328-337.
21. O'Rielly D.D., Loomis C.W. Spinal prostaglandins facilitate exaggerated A- and C-fiber-mediated reflex responses and are critical to the development of allodynia early after L5-L6 spinal nerve ligation. Anesthesiology 2007, 106:795-805.
22. Padi S.S., Kulkarni S.K. Differential effects of naproxen and rofecoxib on the development of hypersensitivity following nerve injury in rats. Pharmacol Biochem Behav 2004, 79:349-358.
23. Seybold V.S., Jia Y.P., Abrahams L.G. Cyclo-oxygenase-2 contributes to central sensitization in rats with peripheral inflammation. Pain 2003, 105:47-55.
24. Sinatra R. Role of COX-2 inhibitors in the evolution of acute pain management. J Pain Symptom Manage 2002, 24:S18-S27.
25. Solomon C.D. Cyclooxygenase-2 inhibitors and cardiovascular risk. Curr Opin Cardiol 2006, 21:613-617.
26. Svensson C.I., Yaksh T.L. The spinal phospholipase-cyclooxygenase-prostanoid cascade in nociceptive processing. Annu Rev Pharmacol Toxicol 2002, 42:553-583.
27. Syriatowicz J.P., Hu D., Walker J.S., Tracey D.J. Hyperalgesia due to nerve injury: role of prostaglandins. Neuroscience 1999, 94:587-594.
28. Takahashi M., Kawaguchi M., Shimada K., Konishi N., Furuya H., Nakashima T. Cyclooxygenase-2 expression in Schwann cells and macrophages in the sciatic nerve after single spinal nerve injury in rats. Neurosci Lett 2004, 363:203-206.
29. Vanegas H., Schaible H.G. Prostaglandins and cyclooxygenases [correction of cycloxygenases] in the spinal cord. Prog Neurobiol 2001, 64:327-363.
30. Yaksh T.L., Dirig D.M., Conway C.M., Svensson C., Luo Z.D., Isakson P.C. The acute antihyperalgesic action of nonsteroidal, anti-inflammatory drugs and release of spinal prostaglandin E2 is mediated by the inhibition of constitutive spinal cyclooxygenase-2 (COX-2) but not COX-1. J Neurosci 2001, 21:5847-5853.
31. Zhao Z., Chen S.R., Eisenach J.C., Busija D.W., Pan H.L. Spinal cyclooxygenase-2 is involved in development of allodynia after nerve injury in rats. Neuroscience 2000, 97:743-748.
32. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 1983, 16:109-110.